Mandate Investor Growth Capital new principle owner in Doxa

July 19, 2006

Through a special issue of shares, Investor Growth Capital will become the principle owner of the Uppsala-based medical technology company Doxa. Doxa develops new biomaterial for medical use. Since 2002, work has concentrated on rapidly growing field of orthopaedics. The infusion of capital will finance continued development of their biomaterial.

Vinge acted as advisor to Investor Growth Capital. Vinge representatives included Johan Winnerblad and Tom Zachrisson.

Jerker Kjellander is a new partner in Skåne

Dispute resolution expert Jerker Kjellander has been elected as a partner in Vinge’s Skåne office.
November 20, 2020

Amendments to the Swedish Competition Act provide extended powers for the Swedish Competition Authority

Early in 2021, the Swedish Competition Act (2008: 579) will be amended in several important respects. The background to the amendments is Directive (EU) 2019/1 of the European Parliament and of the Council, which aims to harmonize the investigative and sanctioning powers of the European competition authorities in their enforcement of the EU competition rules. Undertakings active in Sweden will be affected by the amendments in several ways.
October 12, 2020